Country

Clinical trials in Taiwan

Active obesity and GLP-1 studies with at least one location in Taiwan.

30active studies

18recruiting now

10countries represented

56largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowNot applicable

Multi-Modal Digital Interventions for Adolescent Weight Management

Obesity, Adolescent, Weight Change, BodyCondition

Multi-Modal Digital InterventionTreatment

Taiwan2 locations

National Yang Ming Chiao Tung UniversitySponsor

Updated 2026-09-08 · NCT06920862See eligibility →

Recruiting nowNot applicable

The NTU JO-SMART Study

Knee Osteoarthristis, Diabetes (DM)Condition

NTU-JO Smart ProgramTreatment

Taiwan2 locations

National Taiwan University HospitalSponsor

Updated 2026-07-24 · NCT07317310See eligibility →

Recruiting nowNot applicable

Taiwan Green Propolis for Blood Lipids and Body Fat in Patients With MASLD

Metabolic Dysfunction-Associated Steatotic Liver Disease, Non-alcoholic Fatty Liver Disease NAFLDCondition

Taiwan green propolis capsule, Placebo capsuleTreatment

Taiwan1 locations

Taipei Medical UniversitySponsor

Updated 2026-07-09 · NCT07692438See eligibility →

Recruiting nowNot applicable

OCEAN Registry: Obesity and Clock for Elegant Aging Registry

Obesity, Circadian DysregulationCondition

Intervention not listedTreatment

Taiwan1 locations

Chang Gung Memorial HospitalSponsor

Updated 2026-06-23 · NCT02674230See eligibility →

Recruiting nowNot applicable

Improving Outcomes After AF Ablation in Obese Patients

Atrial Fibrillation (AF), Obesity (Disorder)Condition

Cardiac Rehabilitation and Lifestyle Modification, Usual CareTreatment

Taiwan1 locations

National Taiwan University HospitalSponsor

Updated 2026-06-01 · NCT07618741See eligibility →

Recruiting nowNot applicable

The Evaluation of Orange Peel Fermentation on Body Fat Lowering Efficacy in Adults

Overweight, Fatty Liver DiseaseCondition

Placebo, orange peel fermentationTreatment

Taiwan1 locations

TCI Co., Ltd.Sponsor

Updated 2026-05-29 · NCT04496895See eligibility →

Recruiting nowNot applicable

Comparative Observation of Metabolic and Pharmacologic Adipose Remodeling With Enhanced Incretin AgonisTs

Obesity and Metabolic SyndromeCondition

Tirzepatide with lifestyle modification, Semaglutide with lifestyle modificationTreatment

Taiwan1 locations

Tri-Service General Hospital (TSGH)Sponsor

Updated 2026-05-15 · NCT07589322See eligibility →

Recruiting nowNot applicable

Rutazyme Lemon Fermented Product Capsules for Metabolic Function in Adults With Obesity

Obesity, Metabolic SyndromeCondition

Rutazyme® Lemon Fermented Product Capsule, Placebo Capsule (Maltodextrin; GLUCIDEX®12)Treatment

Taiwan1 locations

National Taiwan Sport UniversitySponsor

Updated 2026-04-21 · NCT07540949See eligibility →

Recruiting nowNot applicable

Strategic Lifestyle Intervention for Metabolic Syndrome (SLIM-MET)

Metabolic SyndromeCondition

Strategic lifestyle and drug interventions, ControlTreatment

Taiwan1 locations

National Health Research Institutes, TaiwanSponsor

Updated 2026-04-08 · NCT06271200See eligibility →

Recruiting nowNot applicable

A Wearable Device and AI-Supported Diet and Exercise Intervention

Obesity and Obesity-related Medical ConditionsCondition

A Wearable Device and AI-Supported Diet and Exercise intervention, standard careTreatment

Taiwan2 locations

National Taiwan University HospitalSponsor

Updated 2026-03-25 · NCT06630663See eligibility →

Recruiting nowNot applicable

Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women

Menopause, PerimenopauseCondition

Multi-acupoint low-level laser therapy, Sham Laser irradiationTreatment

Taiwan1 locations

Chang Gung Memorial HospitalSponsor

Updated 2026-03-20 · NCT07472881See eligibility →

Recruiting nowNot applicable

NUTRIMOOD-Inflammation and Depressive Comorbidity in Obesity: Modulation by Omega-3 Polyunsaturated Fatty Acids Status

Obese Adults, MDDCondition

Eicosapentaenoic acid (omega-3 fatty acid), PlaceboTreatment

Taiwan1 locations

National Science and Technology Council, TaiwanSponsor

Updated 2026-02-27 · NCT07439744See eligibility →

Recruiting nowNot applicable

Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases

Metabolic Syndrome (MetS), Obesity & OverweightCondition

No interventionTreatment

Taiwan1 locations

Chang Gung Memorial HospitalSponsor

Updated 2025-11-25 · NCT07248371See eligibility →

Recruiting nowNot applicable

Spontaneous Breathing Trials Using Pressure Support or T-Piece in Overweight and Obese Patients

Mechanical Ventilation, ExtubationCondition

Spontaneous breathing trial using pressure support ventilation, Spontaneous breathing trial using T-PieceTreatment

Taiwan1 locations

Taipei Medical University HospitalSponsor

Updated 2025-11-17 · NCT07114289See eligibility →

Recruiting nowNot applicable

Effects of GLP-1 Formula on GLP-1 and Glucose Regulation

OverweightCondition

GLP-1 formula GroupTreatment

Taiwan1 locations

Shih Chien HuangSponsor

Updated 2025-07-24 · NCT07082062See eligibility →

Recruiting nowNot applicable

Effectiveness of a Peer Support Media Model on Obesity and Sarcopenia Awareness in At-Risk College Students

Exercise AdherenceCondition

Exercise with video on media platform, Printed Educational HandoutTreatment

Taiwan1 locations

China Medical University HospitalSponsor

Updated 2025-05-11 · NCT06964880See eligibility →

Recruiting nowPhase 1, Phase 2

Integrated Traditional Chinese Medicine Day Care Program for Metabolic Syndrome

Obesity, Metabolic SyndromeCondition

A fiixed combination of Chinese herbal medicine, Laser acupunctureTreatment

Taiwan1 locations

Chang Gung Memorial HospitalSponsor

Updated 2024-11-25 · NCT06703788See eligibility →

Recruiting nowNot applicable

Taiwan Diabesity Study:Comparison With Mild Obese T2DM Patients Who Under Metabolic Surgery

DiabetesCondition

Observation of natural course of Diabetes Mellitus Type 2Treatment

Taiwan1 locations

Min-Sheng General HospitalSponsor

Updated 2014-06-18 · NCT02166372See eligibility →

Opening soonNot applicable

Generative AI-Based Health Education for Older Adults With Sarcopenic Obesity

Sarcopenic ObesityCondition

Generative AI-based text materials, Generative AI-based video materialsTreatment

Taiwan1 locations

Taipei Medical UniversitySponsor

Updated 2026-08-24 · NCT07782320See eligibility →

Opening soonNot applicable

Acupoint Catgut Embedding With Laser Acupuncture for Weight Loss in Adults With Obesity

Obesity, Obesity, AbdominalCondition

Acupoint catgut embedding, Active laser acupunctureTreatment

Taiwan1 locations

Taipei City HospitalSponsor

Updated 2026-08-18 · NCT07770893See eligibility →

Opening soonNot applicable

Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation

Atrial Fibrillation Ablation, Persistent Atrial FibrillationCondition

Tirzepatide, Standard Care (in control arm)Treatment

Taiwan1 locations

National Taiwan University HospitalSponsor

Updated 2026-06-12 · NCT07382024See eligibility →

Opening soonPhase 3

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

Diabetes Mellitus, Type 2Condition

CagriSema (Cagrilintide B and Semaglutide I), Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)Treatment

Argentina, Brazil56 locations

Novo Nordisk A/SSponsor

Updated 2026-05-28 · NCT07282613See eligibility →

Opening soonNot applicable

Effects of a GLP-1 Formula Drink on Gut Microbiota and Glycemic Control in Prediabetic Individuals

Obesity, PrediabetesCondition

GLP-1 formula liquid drink, PlaceboTreatment

Taiwan1 locations

Chung Shan Medical UniversitySponsor

Updated 2025-07-28 · NCT07089732See eligibility →

Opening soonPhase 4

The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms

Glucagon-Like Peptide-1 Receptor Agonists, Type 2 DiabetesCondition

Semaglutide 1.0 mg, Semaglutide 0.5 mgTreatment

Taiwan1 locations

Taipei Veterans General Hospital, TaiwanSponsor

Updated 2025-07-18 · NCT07073053See eligibility →

Invitation onlyPhase 4

Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV

Human Immunodeficiency Virus (HIV), Metabolic Dysfunction Associated Steatotic Liver DiseaseCondition

TirzepatideTreatment

Taiwan1 locations

National Taiwan University Clinical Trial CenterSponsor

Updated 2026-07-20 · NCT07707778See eligibility →

Invitation onlyNot applicable

A Prospective Cohort Study on Patient With Obesity Undergoing Weight Change

Obesity & Overweight, Weight LossCondition

Intervention not listedTreatment

Taiwan1 locations

National Taiwan University HospitalSponsor

Updated 2026-03-30 · NCT07239167See eligibility →

Invitation onlyNot applicable

The Effects of Kefir on Pediatric Obesity

ObesityCondition

Kefir peptide, PlaceboTreatment

Taiwan1 locations

China Medical University HospitalSponsor

Updated 2025-12-10 · NCT06500104See eligibility →

Active, not recruitingNot applicable

Comparative Effectiveness of Western Pharmacotherapy Versus Integrative Western and Traditional Chinese Medicine for Weight Management in Central Taiwan: A Real-World Cohort Study

Obesity & OverweightCondition

Intervention not listedTreatment

Taiwan1 locations

National Yang Ming Chiao Tung UniversitySponsor

Updated 2026-06-12 · NCT07646457See eligibility →

Active, not recruitingNot applicable

Function Definition and Clinical Validation of Digital Health App: Using Weight Management as An Example

Weight Loss, Body Fat Rate LossCondition

"AI Mindful Eating" App, Outpatient regular follow-upTreatment

Taiwan1 locations

National Cheng-Kung University HospitalSponsor

Updated 2026-01-29 · NCT06380920See eligibility →

Active, not recruitingNot applicable

Suture Length Effects in Acupoint Implantation for Abdominal Obesity

Abdominal Obesity, ObesityCondition

1 inch, 0.5 inchTreatment

Taiwan1 locations

Chang Gung Memorial HospitalSponsor

Updated 2025-08-15 · NCT07125716See eligibility →

Related countries

United States1,107 China326 Canada158 France110 Spain98 Germany95

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.